Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variability in zidovudine serum concentrations

C V Fletcher1, H H Balfour

  • 1Department of Pharmacy Practice, University of Minnesota Academic Health Sciences Center, Minneapolis 55455, USA.

Pharmacotherapy
|November 1, 1996
PubMed
Summary

This study highlights significant variability in zidovudine (AZT) serum concentrations. Computer simulations suggest weight-adjusted dosing may reduce this variability in HIV patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

The Journal of antimicrobial chemotherapy·2020
Same author

Screening for Epstein-Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method.

Epidemiology and infection·2019
Same author

The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: A prospective study.

Pediatric transplantation·2017
Same author

Pharmacokinetics of tenofovir during pregnancy and postpartum.

HIV medicine·2015
Same author

Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2013
Same author

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo.

Clinical pharmacology and therapeutics·2010

Area of Science:

  • Pharmacokinetics
  • Computational Biology
  • HIV/AIDS Therapeutics

Background:

  • Zidovudine (AZT) is a cornerstone antiretroviral medication.
  • Interpatient variability in drug concentrations can impact treatment efficacy and toxicity.
  • Understanding pharmacokinetic variability is crucial for optimizing AZT dosing regimens.

Purpose of the Study:

  • To explore the variability of zidovudine serum concentrations using computer simulations and measured data.
  • To evaluate the potential of a weight-adjusted dosing strategy to reduce interpatient variability.
  • To provide a basis for developing optimized dosing strategies for zidovudine.

Main Methods:

  • A one-compartment oral absorption model was utilized to characterize zidovudine disposition.
  • Monte Carlo simulations were performed to predict zidovudine concentrations after repetitive oral dosing.
  • Predicted concentrations were compared with measured serum concentrations from HIV-infected patients.

Main Results:

  • Simulations revealed substantial variability in predicted zidovudine concentrations (0.52-5.18 microM).
  • Measured zidovudine concentrations in patients showed similar variability (0.54-3.07 microM).
  • A weight-adjusted dosing regimen simulation indicated a potential reduction in concentration variability.

Conclusions:

  • Significant interpatient variability exists in zidovudine serum concentrations.
  • Weight-adjusted dosing is a potential strategy to mitigate zidovudine concentration variability.
  • Further research into dosing strategies is warranted to control pharmacokinetic and pharmacodynamic variability.

Related Experiment Videos